Adverse events · people with transtibial amputation due to peripheral arterial disease or diabetes
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · people requiring treatment for chronic DVT
1 finding from 1 review
Adverse events · people requiring treatment for chronic DVT
Chronic DVT ‐ antiplatelet agents plus BMP showed no clear difference in adverse events compared with BMP plus placebo (moderate certainty).
1 finding from 1 review
Adverse events · people requiring treatment for acute DVT
It is very uncertain whether acute DVT ‐ antiplatelet agents plus BMP changes adverse events compared with BMP alone (very low certainty).
1 finding from 1 review
Adverse events · adults with ALI
It is very uncertain whether ultrasound‐accelerated thrombolysis changes adverse events compared with thrombolysis alone (very low certainty).
1 finding from 1 review
Adverse events · people undergoing bariatric surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · primary Raynaud's phenomenon
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · primary Raynaud's phenomenon
1 finding from 1 review
Adverse events · patients with venous insufficiency
Do phlebotonics improve signs and symptoms of venous insufficiency… probably leads to higher adverse events compared with placebo? (moderate certainty).
1 finding from 1 review
Adverse events · people undergoing major amputation of the lower extremity
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · people with critical limb ischaemia
Clinprost showed no clear difference in adverse events compared with lipo‐PGE1 (moderate certainty).
1 finding from 1 review
Adverse events – pain · people with transtibial amputation due to peripheral arterial disease or diabetes
1 finding from 1 review
Adverse events(during · children or adults with Types I or II HAE
Berotralstat showed no clear difference in adverse events(during compared with placebo or active control (moderate certainty).
1 finding from 1 review
Adverse events(during · children or adults with Types I or II HAE
Plasma‐derived C1 esterase inhibitor showed no clear difference in adverse events(during compared with placebo or active control (low certainty).
1 finding from 1 review
Adverse events(during · children or adults with Types I or II HAE
Recombinant human C1 esterase inhibitor showed no clear difference in adverse events(during compared with placebo or active control (low certainty).
1 finding from 1 review
Adverse events(during · children or adults with Types I or II HAE
Lanadelumab showed no clear difference in adverse events(during compared with placebo or active control (low certainty).
1 finding from 1 review
Adverse events (pain) · adults requiring dorsalis pedis artery catheterisation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events (pain) · adults requiring radial artery catheterisation
1 finding from 1 review
Adverse events (pain) · adults requiring radial artery catheterisation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events (pain) · adults requiring radial artery catheterisation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found